Fox Run Management »

Dianthus Therapeutics shares owned by Fox Run Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Fox Run Management from 13F filings

Historical chart of Fox Run Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Fox Run Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $433k 11k 41.21

More positions owned by Fox Run Management

Select Sector Spdr Tr State Street Fin (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Zebra Technologies Corporati Cl A (ZBRA)
Blackrock (BLK)
Ralph Lauren Corp Cl A (RL)
Roblox Corp Cl A (RBLX)
Wabtec Corporation (WAB)
Hubspot (HUBS)
Garmin SHS (GRMN)
Rockwell Automation (ROK)
Jfrog Ord Shs (FROG)
Godaddy Cl A (GDDY)
Northrop Grumman Corporation (NOC)
Msci (MSCI)

View all positions for Fox Run Management

Top funds holding Dianthus Therapeutics

FMR
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Fairmount Funds Management
Avidity Partners Management
Vanguard Group
BlackRock
TCG Crossover Management
State Street Corporation
Braidwell
Point72 Asset Management
Citadel Advisors
Marshall Wace
Polar Capital Holdings

View all funds holding Dianthus Therapeutics